Hemogenyx Pharmaceuticals Plc Stock Analysis
| HOPHF Stock | USD 0 0.00 0.00% |
Hemogenyx Pharmaceuticals Plc is overvalued with Real Value of 0.002604 and Hype Value of 0.0031. The main objective of Hemogenyx Pharmaceuticals pink sheet analysis is to determine its intrinsic value, which is an estimate of what Hemogenyx Pharmaceuticals Plc is worth, separate from its market price. There are two main types of Hemogenyx Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Hemogenyx Pharmaceuticals pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Hemogenyx Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Hemogenyx |
Hemogenyx Pink Sheet Analysis Notes
About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hemogenyx Pharmaceuticals recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was founded in 2012 and is headquartered in London, the United Kingdom. Hemogenyx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.The quote for Hemogenyx Pharmaceuticals Plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Hemogenyx Pharmaceuticals Plc call Vladislav Sandler at 44 79 0917 7311 or check out https://www.hemogenyx.com.Hemogenyx Pharmaceuticals Investment Alerts
| Hemogenyx Pharmaceuticals generated a negative expected return over the last 90 days | |
| Hemogenyx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Hemogenyx Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (5.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemogenyx Pharmaceuticals Plc has accumulated about 6.84 M in cash with (2.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company shares are held by company insiders |
Hemogenyx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemogenyx Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hemogenyx Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Hemogenyx Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Hemogenyx Pharmaceuticals Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Hemogenyx Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Hemogenyx Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Hemogenyx Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Hemogenyx Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hemogenyx shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Hemogenyx Pharmaceuticals. By using and applying Hemogenyx Pink Sheet analysis, traders can create a robust methodology for identifying Hemogenyx entry and exit points for their positions.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was founded in 2012 and is headquartered in London, the United Kingdom. Hemogenyx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Hemogenyx Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |